Krilogy Financial’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,528
Closed -$156K – 1149
2026
Q2
$156K Sell
11,528
-4,981
-30% -$59.6K ﹤0.01% 981
2026
Q1
$154K Sell
16,509
-5,603
-25% -$42.2K 0.01% 918
2025
Q4
$201K Sell
22,112
-761
-3% -$6.01K 0.01% 877
2025
Q3
$146K Buy
+22,873
New +$224K 0.01% 834

Other funds holding OGN

Krilogy Financial's OGN Position: Q3 2026 in Review

Krilogy Financial sold out of Organon & Co (OGN) in Q3 2026, closing a stake of 11,528 shares — an estimated $156K sold.

Krilogy Financial first reported a position in OGN in Q3 2025 and held it in 4 quarters. The position peaked at $201K in Q4 2025. 289 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Krilogy Financial reported no remaining Organon & Co position as of Q3 2026 after selling out during the quarter.
  • Krilogy Financial sold 11,528 Organon & Co shares in Q3 2026, an estimated $156K.
  • Krilogy Financial first reported a position in Organon & Co in Q3 2025 and held it in 4 quarters.
  • Krilogy Financial's Organon & Co position peaked at $201K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Krilogy Financial's 13F filing for Q3 2026, filed 13 Oct 2026.